FENC Earnings FENNEC PHARMACEUTICALS INC.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | 0.01 | 2026-05-14 | 10-Q |
| FY 2025 | 2025-12-31 | -0.34 | 2026-03-27 | 10-K |
| Q3 2025 | 2025-09-30 | -0.18 | 2025-11-13 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.16 | 2025-08-14 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.04 | 2026-05-14 | 10-Q |
| FY 2025 | 2024-12-31 | -0.02 | 2026-03-27 | 10-K |
| Q3 2025 | 2024-09-30 | 0.06 | 2025-11-13 | 10-Q |
| Q2 2025 | 2024-06-30 | 0.24 | 2025-08-14 | 10-Q |
| Q1 2025 | 2024-03-31 | 0.41 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -0.60 | 2025-03-26 | 10-K |
| Q3 2024 | 2023-09-30 | -0.50 | 2024-11-08 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.43 | 2024-08-13 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.23 | 2024-05-14 | 10-Q |
| FY 2023 | 2022-12-31 | -0.90 | 2024-03-29 | 10-K |
| Q3 2023 | 2022-09-30 | -0.65 | 2023-11-09 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.34 | 2023-08-07 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.14 | 2023-05-12 | 10-Q |
| FY 2022 | 2021-12-31 | -0.67 | 2023-03-29 | 10-K |
| Q3 2022 | 2021-09-30 | -0.50 | 2022-11-14 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.34 | 2022-08-12 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.